Cortis Medtech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -350.29%
- Ebitda -340.80%
- Net Worth -96.49%
- Total Assets -64.36%
About Cortis Medtech
Cortis Medtech Private Limited (CMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 June 2020 (Four years and eight months 7 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Jayanthi Raja and Periyasamy Raja serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33309KA2020PTC134741
-
Company No.
134741
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jun 2020
-
Date of AGM
26 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Cortis Medtech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Periyasamy Raja
|
Managing Director | 09-Jun-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Jayanthi Raja
|
Director | 01-Jun-2023 | Current |
Financial Performance of Cortis Medtech.
Cortis Medtech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 350.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 96.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cortis Medtech?
In 2022, Cortis Medtech had a promoter holding of 87.29% and a public holding of 12.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cortis Laboratories Private LimitedJayanthi Raja and Periyasamy Raja are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cortis Medtech?
Cortis Medtech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cortis Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortis Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
